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Dear Editor,
In this retrospective study, we compared eti-
ologies and antibiotic susceptibility patterns 
among kidney and liver transplant recipi-
ents with bacteremia in two 1-year periods, 
2005 and 2009. Time of bacteremia onset 
were computed in the two post-transplant 
periods, first six months (early period) and 
more than six months (late period) after 
the transplantation. Clinical characteristics 
including age, sex, previous antibiotic or 
antifungal therapy within three months, co-
morbidities, central venous catheterization 
(CVC), mechanical ventilation, cytomeg-
alovirus (CMV) disease, hemodialysis after 
transplantation, intra-abdominal drainage 
or biliary stenting, origin of bacteremia, al-
lograft dysfunction, mortality, microbiolog-
ical isolates, total parenteral nutrition were 
collected for the analysis. 
There were 14 bacteremic episodes among 
six kidney and eight liver recipients in the year 
2005, and there were 23 episodes among six 
kidney and 17 liver recipients in the year 2009. 
Characteristics of the episodes in the two study 
periods of 2005 and 2009 were similar. Overall, 
there were 15 bacteremic episodes in the early 
period and 22 in the late period. Trimethoprim-
sulphamethoxazole (TMP-SMX) prophylaxis 
(n = 13 vs n = 4, p = 0.0001) and presence of 
CVC (n = 8 vs n = 4, p = 0.025) were more fre-
quently detected in the early post-transplanta-
tion period. However, CMV disease (n = 5 vs 
n = 0) occurred more frequently in the late 
period. Other characteristics of the episodes 
were similar in the two post transplantation 
periods. All infections were caused by Gram-
negative bacteremia (Escherichia coli, n = 16; 
Klebsiella spp., n = 13; Pseudomonas spp., 
n = 5; Acinetobacter baumannii, n = 2; Entero-
bacter aerogenes, n = 1). No significant changes 
in antibiotic resistance patterns were found 
among microorganisms isolated in the years 
2005 and 2009. However, when comparing the 
two post-transplantion periods, the isolates 
recovered during the early period demon-
strated significantly higher resistance rate 
to ceftazidime (p = 0.003) and cefepime 
(p = 0.003) (Table 1). Multivariate logistic 
regression showed that the increased resist-
ance rate to ceftazidime and cefepime was 
associated with onset of bacteremia in the 
early period (OR, 9.12; p = 0.003), TMP-
SMX prophylaxis (OR, 3.40; p = 0.046), and 
intra-abdominal drainage or biliary stent-
ing (OR, 4.61, p = 0.032). 
Table 1. Antibiotic resistance patterns in Gram-negative bacteria causing bacteremia 
in liver and kidney transplantation recipients according to two post-transplantation 
periods, n (%)*
 1-6 months > 6 months p
Ciprofloxacin 6 (46) 7 (54) > 0.05
Ceftazidime 10 (71.4) 4 (28.6) 0.003
Piperacillin-tazobactam 4 (44.2) 5 (55.8) > 0.05
Cefepime 10 (71.4) 4 (28.6) 0.003
Amikacin 1 (100) 0 > 0.05
Imipenem 1 (50) 1(50) > 0.05
* Univariate analysis.
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Microorganisms responsible for infections in our study 
were entirely Gram-negative bacteria, in contrast to the 
publications of Kawecki et al.,1 where the microorgan-
isms responsible for bloodstream infections among solid 
organ recipients were predominantly Gram-positive bacte-
ria. Multiple antibiotic-resistant bacteremia during the early 
period after transplantation observed in our study was also 
described by Linares et al.2 To the best of our knowledge, 
this is the first study reporting TMP-SMX prophylaxis and 
intra-abdominal drainage or biliary stenting as independ-
ent risk factors for resistance to ceftazidime and cefepime in 
bloodstream isolates in this setting of patients. 
In conclusion, Gram-negative bacteria should be con-
sidered if bloodstream infection is suspected among solid 
organ transplant recipients. Multidrug-resistant pathogens 
may especially be of great concern among patients with early 
bacteremia after solid organ transplantation.
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